Use of a screening tool improves appropriate referral to an electrophysiologist for implantable cardioverter-defibrillators for primary prevention of sudden cardiac death

Circulation: Cardiovascular Quality and Outcomes

Volumn 4, Issue 2, 2011, Pages 152-156

  Gravelin, Laura M ^a   Yuhas, Jennifer ^a   Remetz, Michael ^b   Radford, Martha ^c   Foley, John ^d   Lampert, Rachel ^b  

^a St Elizabeth Medical Center   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Norwich Cardiology Associates   (United States)

Author keywords

Diagnosis; Implantable cardioverter defibrillators; Primary prevention; Utilization

Indexed keywords

ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; HEART EJECTION FRACTION; HEART ELECTROPHYSIOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTPATIENT DEPARTMENT; PATIENT REFERRAL; PRIMARY PREVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SUDDEN DEATH;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; MALE; MASS SCREENING; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PRIMARY PREVENTION; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK FACTORS; SEX CHARACTERISTICS; SURVIVAL RATE;

EID: 79959722114     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.110.956987     Document Type: Article

References (19)

1. Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA. 2006;295:809-818. (Pubitemid 43244308)
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp- Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237. (Pubitemid 40110811)
3. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G; Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882-1890.
4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of A defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883. (Pubitemid 34984635)
5. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SCJ, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. Circulation. 2006;114:e385-e484.
6. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Riegel B, Tarkington LG, Yancy CW; American College of Cardiology/ American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery, Society of Thoracic Surgeons. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117:e350-e408.
7. Centers for Medicare & Medicaid Services. Decision memo for implantable cardioverter defibrillators (CAG-00157R3); 2005. Available at: http://www.cms.gov/mcd/viewdecisionmemo.asp?from2- viewdecisionmemo.asp148 Accessed January 19th, 2011.
8. McClellan MB, Tunis SR. Medicare coverage of ICDs. N Engl J Med. 2005;352:222-224. (Pubitemid 40110810)
9. Ruskin JN, Camm AJ, Zipes DP, Hallstrom AP, McGrory-Usset ME. Implantable cardioverter defibrillator utilization based on discharge diagnoses from Medicare and managed care patients. J Cardiovasc Electrophysiol. 2002;13:38-43. (Pubitemid 34113618)
10. Voigt A, Ezzeddine R, Barrington W, Obiaha-Ngwu O, Ganz LI, London B, Saba S. Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001. J Am Coll Cardiol. 2004;44:855-858. (Pubitemid 39099585)
11. Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA, Yancy CW, Albert NM, Peterson ED. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure [see comment]. JAMA. 2007;298:1525-1532.
12. Sanders GP, Yeon SB, Grunes J, Seto TB, Manning WJ. Impact of A specific echocardiographic report comment regarding endocarditis prophylaxis on compliance with American Heart Association recommendations. Circulation. 2002;106:300-303. (Pubitemid 34778951)
13. Heidenreich PA, Gholami P, Sahay A, Massie B, Goldstein MK. Clinical reminders attached to echocardiography reports of patients with reduced left ventricular ejection fraction increase use of beta-blockers: A randomized trial. Circulation. 2007;115:2829-2834. (Pubitemid 46869669)
14. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med. 1993;119:1187-1197. (Pubitemid 23361449)
15. Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez A, Schulman KA. Sex differences in the use of implantable cardioverterdefibrillators for primary and secondary prevention of sudden cardiac death. JAMA. 2007;298:1517-1524. (Pubitemid 47529385)
16. Gauri AJ, Davis A, Hong T, Burke MC, Knight BP. Disparities in the use of primary prevention and defibrillator therapy among blacks and women. Am J Med. 2006;119:167.e17-167.e21.
17. El-Chami MF, Hanna IR, Bush H, Langberg JJ. Impact of race and gender on cardiac device implantations. Heart Rhythm. 2007;4:1420-1426. (Pubitemid 47591397)
18. Schulman KA, Berlin JA, Harless W, Kerner JF, Sistrunk S, Gersh BJ, Dube R, Taleghani CK, Burke JE, Williams S, Eisenberg JM, Escarce JJ. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med. 1999;340:618-626. [Erratum appears in N Engl J Med. 1999;340:1130]. (Pubitemid 29093722)
19. Rathore SS, Ordin DL, Krumholz HM. Race and sex differences in the refusal of cardiac catheterization among elderly patients hospitalized with acute myocardial infarction. Am Heart J. 2002;144:1052-1056. (Pubitemid 36026919)